The diversity of the coordination bond generated a POSS-based fluorescent probe for the reversible detection of Cu(ii), Fe(iii) and amino acids

Kun Zhang, Xiaoni Wang, Minggang Tian, Zhiming Gou and Yujing Zuo

J. Mater. Chem. B, 2021, 9, 9744
DOI: 10.1039/D1TB01947C

Strategies to address key challenges of metallacycle/metallacage-based supramolecular coordination complexes in biomedical applications

Dongdong Xu, Yang Li, Shouchun Yin and Feihe Huang

Chem. Soc. Rev., 2024, 53, 3167
DOI: 10.1039/D3CS00926B

Solid-state emitting twisted π-conjugate as AIE-active DSE-gen:in vitroanticancer properties against FaDu and 4T1 with biocompatibility and bioimaging

Shouvik Bhuin, Pravesh Sharma, Purbali Chakraborty, Onkar Prakash Kulkarni and Manab Chakravarty

J. Mater. Chem. B, 2023, 11, 188
DOI: 10.1039/D2TB02078E

A novel NIR fluorescent probe for in situ visualizing Fe(ii) and its application in drug-induced liver/kidney injury

Hanyue Xiang, Yanjie Song, Yilin Wang, Wenzhuo Fu and Nao Xiao

Mater. Adv., 2024, 5, 5624
DOI: 10.1039/D4MA00361F

Huaier Polysaccharide Attenuates Doxorubicin-Induced Acute Cardiotoxicity by Regulating Ferroptosis

X. Ma, H. Gao, B. Yang, H. Zhao and Z. Zhu

Bull Exp Biol Med, 2022, 174, 37
DOI: 10.1007/s10517-022-05644-7

Iron–Doxorubicin Hyaluronan Nanogel as an Effective Targeted Chemotherapy with Modulated Cardiotoxicity

Hua Guo, Huimin Wang, Yiyi Zhang, Hong Deng, Ching-Hsuan Tung and Weiqi Zhang

Biomacromolecules, 2025, 26, 1614
DOI: 10.1021/acs.biomac.4c01397

Pharmacological strategies to reduce anthracycline-associated cardiotoxicity in cancer patients

Anna Stansfeld, Utsav Radia, Caitriona Goggin, Preethika Mahalingam, Charlotte Benson, Andrea Napolitano, Robin L Jones, Stuart D Rosen and Vasilios Karavasilis

Expert Opinion on Pharmacotherapy, 2022, 23, 1641
DOI: 10.1080/14656566.2022.2124107

Coenzyme Q10 protects against doxorubicin-induced cardiomyopathy via antioxidant and anti-apoptotic pathway

Dalia A. Shabaan, Nora Mostafa, Manal M. El-Desoky and Eetmad A. Arafat

Tissue Barriers, 2023, 11
DOI: 10.1080/21688370.2021.2019504

The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review

Rony Abdi Syahputra, Urip Harahap, Aminah Dalimunthe, M. Pandapotan Nasution and Denny Satria

Molecules, 2022, 27, 1320
DOI: 10.3390/molecules27041320

Modulation of Doxorubicin-Induced ROS Accumulation in Cardiomyocytes Using Ibuprofen-Conjugated Synthetic Lipids as Carriers

Soumya Saroj, Akshaya Kana Veedu, Chandrasekhar Reddy U, Nalini Venkatesan, Abhishek K. Verma and Muraleedharan Kannoth Manheri

ACS Appl. Bio Mater., 2025, 8, 4673
DOI: 10.1021/acsabm.4c01932

Diphenyl Diselenide Mitigates Renal and Thyroid Dysfunction Associated With Doxorubicin Administration in Wistar Rats

Adesina A. Babalola, Oluwatobiloba F. Da‐Silva, Adedoyin R. Adelowo, Isaac A. Adedara and Ebenezer O. Farombi

J Biochem & Molecular Tox, 2025, 39
DOI: 10.1002/jbt.70431

Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity

Bin Bin Wu, Kam Tong Leung and Ellen Ngar-Yun Poon

IJMS, 2022, 23, 1912
DOI: 10.3390/ijms23031912

Doxorubicin and cyclophosphamide mode of chemotherapy–related cardiomyopathy: Review of preclinical model

Ashot Avagimyan, Lev Kakturskiy, Nana Pogosova, Giulia Ottaviani, Manfredi Rizzo and Nizal Sarrafzadegan

Current Problems in Cardiology, 2025, 50, 102882
DOI: 10.1016/j.cpcardiol.2024.102882

Mitochondria-Targeted Microneedles Reverse Doxorubicin Resistance via Apoptosis-Ferroptosis Synergy

Tianshu Hao, Hanze Guo, Chenyuan Wang, Shisuo Jing, Wen Zhang, Yongnian Zeng, Jinxuan Hou, Zhiyin Song and Wei Li

ACS Nano, 2025, 19, 23315
DOI: 10.1021/acsnano.5c06302

Biocompatible FePO4 Nanoparticles: Drug Delivery, RNA Stabilization, and Functional Activity

Sagar Rayamajhi, Sarah Wilson, Santosh Aryal and Robert DeLong

Nanoscale Res Lett, 2021, 16
DOI: 10.1186/s11671-021-03626-8

Cardiotoxicity Induced by Anticancer Therapies: A Call for Integrated Cardio-Oncology Practice

Giuliana Ciappina, Luigi Colarusso, Enrica Maiorana, Alessandro Ottaiano, Tindara Franchina, Antonio Picone, Gaetano Facchini, Chiara Barraco, Antonio Ieni, Maurizio Cusmà Piccione, Concetta Zito and Massimiliano Berretta

Pharmaceuticals, 2025, 18, 1399
DOI: 10.3390/ph18091399

Urolithin A’s Antioxidative, Anti-Inflammatory, and Antiapoptotic Activities Mitigate Doxorubicin-Induced Liver Injury in Wistar Rats

Shahid Karim, Batoul Madani, Abdulhadi S. Burzangi, Mohammed Alsieni, Mohammed A. Bazuhair, Maha Jamal, Hussam Daghistani, Mohammed O. Barasheed, Huda Alkreathy, Mohammad Ahmed Khan and Lateef M. Khan

Biomedicines, 2023, 11, 1125
DOI: 10.3390/biomedicines11041125

Cardiomyopathies and a brief insight into DOX-induced cardiomyopathy

Sampat Singh Tanwar, Sumeet Dwivedi, Sheema Khan and Seema Sharma

Egypt Heart J, 2025, 77
DOI: 10.1186/s43044-025-00628-0

Investigation of the impact of rosuvastatin and telmisartan in doxorubicin-induced acute cardiotoxicity

Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Afrah Fahad Alkhuriji, Wafa Abdullah I. Al-Megrin, Engy Elekhnawy, Walaa A. Negm, Michel De Waard and Gaber El-Saber Batiha

Biomedicine & Pharmacotherapy, 2022, 154, 113673
DOI: 10.1016/j.biopha.2022.113673

Recent advances and futuristic potentials of nano-tailored doxorubicin for prostate cancer therapy

Rana Sawpari, Sovan Samanta, Jhimli Banerjee, Swarnali Das, Shib Shankar Dash, Rubai Ahmed, Biplab Giri and Sandeep Kumar Dash

Journal of Drug Delivery Science and Technology, 2023, 81, 104212
DOI: 10.1016/j.jddst.2023.104212

Application of Optical Methods for Determination of Concentration of Doxorubicin in Blood and Plasma

Tomasz Sikora, Karolina Morawska, Wiesław Lisowski, Paweł Rytel and Agnieszka Dylong

Pharmaceuticals, 2022, 15, 112
DOI: 10.3390/ph15020112

Women’s Special Issue Series: Biomedicines

Letizia Polito

Biomedicines, 2024, 12, 471
DOI: 10.3390/biomedicines12030471

Redox responsive functionalised mesoporous silica nanoparticle for targeted drug delivery of doxorubicin

Seyedeh Sahar Mojtabazadeh, Mahnoosh Samadi, Sahra Perseh, Saba Saei, Reza Bafkari, Fatemeh Atyabi and Rassoul Dinarvand

Journal of Drug Targeting, 2025, 1
DOI: 10.1080/1061186X.2025.2560592

Cardioprotective and Antioxidant Efficiency of Balanites aegyptiaca Extract Against Doxorubicin® Complication

Heba F. Gomaa, Khaled G. Abdel-W, Mahmoud Ashry and Doaa Galal EL-S

Pakistan J. of Biological Sciences, 2022, 25, 270
DOI: 10.3923/pjbs.2022.270.281

Indispensable role of microbes in anticancer drugs and discovery trends

Ridam Kapoor, Anamika Saini and Deepika Sharma

Appl Microbiol Biotechnol, 2022, 106, 4885
DOI: 10.1007/s00253-022-12046-2

Severe hepatic sinusoidal obstruction syndrome in a patient with Wilms tumor and hereditary spherocytosis

Dildar Bahar Genc, Zeynep Yildiz Yildirmak, Ferhat Sari and Ismail Uzak

Int Canc Conf J, 2023, 13, 93
DOI: 10.1007/s13691-023-00641-7

Multifunctional Fe3O4-PEI@HA nanoparticles in the ferroptosis treatment of hepatocellular carcinoma through modulating reactive oxygen species

Ziwei Liang, Yuhui Wang, Jiapu Wang, Tao Xu, Shilong Ma, Qi Liu, Liqin Zhao, Yan Wei, Xiaojie Lian and Di Huang

Colloids and Surfaces B: Biointerfaces, 2023, 227, 113358
DOI: 10.1016/j.colsurfb.2023.113358

Long non-coding RNAs and microRNAs as crucial regulators in cardio-oncology

Sarath Babu Nukala, Jordan Jousma, Yoonje Cho, Won Hee Lee and Sang-Ging Ong

Cell Biosci, 2022, 12
DOI: 10.1186/s13578-022-00757-y

The Adaptation of MCF-7 Breast Cancer Spheroids to the Chemotherapeutic Doxorubicin: The Dynamic Role of Phase I Drug Metabolizing Enzymes

Daniel Crispim, Carolina Ramos, Francisco Esteves and Michel Kranendonk

Metabolites, 2025, 15, 136
DOI: 10.3390/metabo15020136

Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline‐Induced Cardiomyopathy – A COG‐ALTE03N1 Report

Purnima Singh, Disheet A. Shah, Mariam Jouni, Romina B. Cejas, David K. Crossman, Tarek Magdy, Shaowei Qiu, Xuexia Wang, Liting Zhou, Noha Sharafeldin, Lindsey Hageman, Donald E. McKenna, Saro H. Armenian, Frank M. Balis, Douglas S. Hawkins, Frank G. Keller, Melissa M. Hudson, Joseph P. Neglia, A Kim Ritchey, Jill P. Ginsberg, Wendy Landier, Ravi Bhatia, Paul W. Burridge and Smita Bhatia

JAHA, 2023, 12
DOI: 10.1161/JAHA.123.029954

Hollow mesoporous Prussian blue nanozymes alleviate doxorubicin-induced cardiotoxicity by restraining oxidative stress associated with Nrf2 signaling

Fang Wang, Ke Wang, BaoRu Fang, SiQi Geng, Ying Li, HuiFeng Qian, YiNuo Lin and ZhangSen Yu

Journal of Colloid and Interface Science, 2025, 686, 1074
DOI: 10.1016/j.jcis.2025.02.033

Multifaceted Cardioprotective Potential of Reduced Glutathione Against Doxorubicin-Induced Cardiotoxicity via Modulating Inflammation–Oxidative Stress Axis

Amr Negm, Ezat A. Mersal, Amal F. Dawood, Amira O. Abd El-Azim, Omar Hasan, Rayan Alaqidi, Ahmed Alotaibi, Mohammed Alshahrani, Abdullah Alheraiz and Tamer M. Shawky

IJMS, 2025, 26, 3201
DOI: 10.3390/ijms26073201

Ferroptosis: Latest evidence and perspectives on plant‐derived natural active compounds mitigating doxorubicin‐induced cardiotoxicity

Boyu Wang, Jiameng Wang, Changxing Liu, Chengjia Li, Tianwei Meng, Jia Chen, Qingnan Liu, Wang He, Zhiping Liu and Yabin Zhou

J of Applied Toxicology, 2025, 45, 135
DOI: 10.1002/jat.4670

The Complex Dynamic of Phase I Drug Metabolism in the Early Stages of Doxorubicin Resistance in Breast Cancer Cells

Isabel S. Barata, Bruno C. Gomes, António S. Rodrigues, José Rueff, Michel Kranendonk and Francisco Esteves

Genes, 2022, 13, 1977
DOI: 10.3390/genes13111977

The Electrostatic‐Mediated Formation of a Coordination Complex: the Trapping and Release of an Antitumor Drug with an Anthracycline Core from {Mo72Fe30}‐Based Ensembles

Margarita O. Tonkushina, Kirill V. Grzhegorzhevskii, Alexander A. Ermoshin, Anastasia S. Tugbaeva, Grigory A. Kim, Olga S. Taniya, Ilya D. Gagarin and Alexander A. Ostroushko

ChemistrySelect, 2022, 7
DOI: 10.1002/slct.202203684

Cardiotoxicity of anticancer chemotherapy and possible therapeutic approaches

I. I. Gasanow and T. Kh. Temirsyltanova

Medicinskij sovet, 2025, 201
DOI: 10.21518/ms2025-141

Dual-Responsive multifunctional “core–shell” magnetic nanoparticles promoting Fenton reaction for tumor ferroptosis therapy

Hao Chi, Guang Zhu, Yalin Yin, He Diao, Zicheng Liu, Shibo Sun, Zhaoming Guo, Weiping Xu, Jianqiang Xu, Changhao Cui, Xiao-Jin Xing and Kun Ma

International Journal of Pharmaceutics, 2022, 622, 121898
DOI: 10.1016/j.ijpharm.2022.121898

Relevance of Ferroptosis to Cardiotoxicity Caused by Anthracyclines: Mechanisms to Target Treatments

Guoxia Zhang, Chao Yuan, Xin Su, Jianzhen Zhang, Priyanka Gokulnath, Gururaja Vulugundam, Guoping Li, Xinyu Yang, Na An, Can Liu, Wanli Sun, Hengwen Chen, Min Wu, Shipeng Sun and Yanwei Xing

Front. Cardiovasc. Med., 2022, 9
DOI: 10.3389/fcvm.2022.896792

Chiral Polymer Micelles Alleviate Adriamycin Cardiotoxicity via Iron Chelation and Ferroptosis Inhibition

Tiantian Chen, Yan Qin, Yao Li, Yaru Li, Jiajia Luo, Lanlan Fan, Meiyu Feng, Zheng Wang and Yanjun Zhao

Adv Funct Materials, 2023, 33
DOI: 10.1002/adfm.202300689

BSA-Coated Copper Ferrite Nanoparticles Loaded with Doxorubicin for Synergistic Ferroptosis-Chemotherapy for Cancer Treatment

Yanzhao Yin, Ying Lu, Sijia Lin, Lin Wang, Ziyi Wang, Xue Dong, Jin Cao, Lin Wu and Song Shen

ACS Appl. Bio Mater., 2025, 8, 7322
DOI: 10.1021/acsabm.5c00999

Triad role of hepcidin, ferroportin, and Nrf2 in cardiac iron metabolism: From health to disease

Deepthy Jayakumar, Kishore Kumar S. Narasimhan and Kalaiselvi Periandavan

Journal of Trace Elements in Medicine and Biology, 2022, 69, 126882
DOI: 10.1016/j.jtemb.2021.126882

Small Molecules Targeting Mitochondria: A Mechanistic Approach to Combating Doxorubicin-Induced Cardiotoxicity

Chinmay Pal

Cardiovasc Toxicol, 2025, 25, 216
DOI: 10.1007/s12012-024-09941-7

Exercise and Doxorubicin Modify Markers of Iron Overload and Cardiolipin Deficiency in Cardiac Mitochondria

Ryan N. Montalvo, Franccesco P. Boeno, Imtiaz M. Dowllah, Cesar E. Jacintho Moritz, Branden L. Nguyen, Vivian Doerr, Matthew P. Bomkamp and Ashley J. Smuder

IJMS, 2023, 24, 7689
DOI: 10.3390/ijms24097689

Anthracycline in Medicinal Chemistry: Mechanism of Cardiotoxicity, Preventive and Treatment Strategies

Narmin Hamaamin Hussen, Aso Hameed Hasan, Gashbeen Osman Muhammed, Akar Yousif Yassin, Roza Rafiq Salih, Parwa Ahmed Esmail, Mohammed M. Alanazi and Joazaizulfazli Jamalis

COC, 2023, 27, 363
DOI: 10.2174/1385272827666230423144150

Innovative metal-sensitized spectrofluorimetric method for the simultaneous determination of resveratrol and doxorubicin in human plasma: A holistic sustainability appraisal

Maha Mohammad Abdel-Monem, Mohamed I. Walash and Asmaa Kamal El-Deen

Talanta Open, 2025, 11, 100447
DOI: 10.1016/j.talo.2025.100447

Ashot Avagimyan, Nana Pogosova, Lev Kakturskiy, Mohammad Sheibani, Abhiram Challa, Eugenia Kogan, Federica Fogacci, Liudmila Mikhaleva, Rositsa Vandysheva, Marianna Yakubovskaya, Andrea Faggiano, Stefano Carugo, Olga Urazova, Behnaz Jahanbin, Ekaterina Lesovaya, Srujana Polana, Kirill Kirsanov, Yasar Sattar, Artem Trofimenko, Tatiana Demura, Amene Saghazadeh, George Koliakos, Davood Shafie, Azin Alizadehasl, Arrigo Cicero, Juan Pablo Costabel, Giuseppe Biondi-Zoccai, Giulia Ottaviani and Nizal Sarrafzadegan

Cardiovascular Pathology, 2024, 73, 107683
DOI: 10.1016/j.carpath.2024.107683

Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection

Marco Bruno Morelli, Chiara Bongiovanni, Silvia Da Pra, Carmen Miano, Francesca Sacchi, Mattia Lauriola and Gabriele D’Uva

Front. Cardiovasc. Med., 2022, 9
DOI: 10.3389/fcvm.2022.847012